A Phase I Study of MK-5108, an Oral Aurora A Kinase Inhibitor, in Both Monotherapy and in Combination with Docetaxel in Patients with Advanced Solid Tumors.
S. E. Minton, Patricia LoRusso, A. Craig Lockhart, Mohd Saif, Smitha Krishnamurthi, Cheryl Ann Pickett-Gies, Y. Wang, Su Guan, E. Roben, Mark N. Stein
We don't know much about this study yet.
We're maintaining the world's largest resposity of hair loss
research. You can help out the community by
sending a PDF of this study here
.
Not sure how to get a study's PDF? You can email the authors
of the study.
